In trading on Friday, shares of Tempus AI Inc (Symbol: TEM) crossed below their 200 day moving average of $54.36, changing hands as low as $53.39 per share. Tempus AI Inc shares are currently trading ...

Investors eyeing a purchase of Tempus AI Inc (Symbol: TEM) shares, but cautious about paying the going market price of $76.57/share, might benefit from considering selling puts among the alternative ...

Tempus AI hopes to leverage artificial intelligence and its massive data set to improve outcomes for patients. It has partnered with nearly all of the top oncology companies. The company grew its ...

Great news for Tempus AI stock! The company has just received FDA approval for an upgraded version of its Tempus Pixel platform — a cardiac imaging system that uses advanced AI to deliver highly ...

Tempus AI TEM operates at the intersection of clinical genomics and AI-driven insights. Its testing and data products are gaining traction with providers and biopharma partners. With revenue up ...

Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF.

Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 14 trades. If we consider the specifics of ...

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology. Tempus is a technology company focused on adopting AI to advance ...

Investors with a lot of money to spend have taken a bullish stance on Tempus AI (NASDAQ:TEM). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Tempus AI is appealing after a 10% pullback, seeing it as an opportunity following strong Q1 results and a short report-driven dip. The precision medicine company should top Q2 estimates, especially ...